7-Chloro-AMT

In this article we are going to explore the topic of 7-Chloro-AMT, which has captured the attention of various areas of study and has generated great interest both in the academic field and in society in general. 7-Chloro-AMT has long been the subject of debate and discussion, and its relevance has become increasingly evident in recent years. This topic has aroused the interest of researchers, scientists, professionals and the general public, due to its impact on different aspects of daily life. Throughout this article, we will explore the different aspects related to 7-Chloro-AMT, analyzing its implications, its history, its influence today and possible future scenarios around this topic.

7-Chloro-AMT
Identifiers
  • 1-(7-chloro-1H-indol-3-yl)propan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC11H13ClN2
Molar mass208.69 g·mol−1
3D model (JSmol)
  • CC(CC1=CNC2=C1C=CC=C2Cl)N
  • InChI=1S/C11H13ClN2/c1-7(13)5-8-6-14-11-9(8)3-2-4-10(11)12/h2-4,6-7,14H,5,13H2,1H3
  • Key:OHEYTFPYHFDAJQ-UHFFFAOYSA-N

7-Chloro-α-methyltryptamine (7-Cl-AMT) is a tryptamine derivative with stimulant effects, invented in the 1960s. It is a weak monoamine oxidase inhibitor but its pharmacology has not otherwise been studied by modern techniques, though several closely related compounds are known to act as serotonin–dopamine releasing agents and agonists of the 5-HT2A receptor.[1][2][3]

See also

References

  1. ^ FR 1344579, Hofmann A, Troxler F, "New indole derivatives and their preparation", published 29 November 1963, assigned to Sandoz SA. 
  2. ^ US 3282959, Robert VJ, Jackson HO, "7-Chloro-alpha-methyltryptamine derivatives.", issued 1 November 1966, assigned to Parke-Davis. 
  3. ^ Blough BE, Landavazo A, Partilla JS, Decker AM, Page KM, Baumann MH, Rothman RB (October 2014). "Alpha-ethyltryptamines as dual dopamine-serotonin releasers". Bioorganic & Medicinal Chemistry Letters. 24 (19): 4754–4758. doi:10.1016/j.bmcl.2014.07.062. PMC 4211607. PMID 25193229.